Recent News

• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.02.2025 - Senti Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
• 09.02.2025 - Senti Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
• 08.19.2025 - Webull Financial Corporate Connect Webinar Series
• 08.19.2025 - Webull Financial Corporate Connect Webinar Series
• 08.14.2025 - Senti Biosciences to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
• 08.14.2025 - Senti Biosciences to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
• 08.12.2025 - Senti Bio Participates in Virtual Investor “What This Means” Segment Discussing The Phase 2 Dose and Schedule Selection for SENTI-202 in its Clinical Trial for Acute Myeloid Leukemia
• 08.12.2025 - Senti Bio Participates in Virtual Investor “What This Means” Segment Discussing The Phase 2 Dose and Schedule Selection for SENTI-202 in its Clinical Trial for Acute Myeloid Leukemia

Recent Filings

• 09.02.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.07.2025 - EX-99.1 EX-99.1
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.07.2025 - 8-K Current report